Together, we innovate, we impact, we grow !
At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company, we’re driven by science, but above all, by the people behind every treatment — the patients and their families.
Through our unique “development only” model, we bring forward promising therapies and transform them into treatments that can reach those who need them most, faster.
We are currently looking for a strategic and hands-on Expert to join our Quality Management department in Lausanne, Switzerland In this high-impact role, you will drive Computerized System Validation (CSV) activities to support our ambitious digitalization initiatives, ensuring our systems remain compliant, efficient, and ready for the future, as a
Permanent role | Lausanne, Switzerland
Your mission is to lead and optimize the CSV strategy for Debiopharm International SA (DPI). You will bridge the gap between innovation and compliance, ensuring that our digital evolution is supported by a robust, risk-based validation framework that protects data integrity and patient safety.
· Strategy & Oversight: Evaluate, design, and implement the CSV strategy for both legacy and new systems, ensuring it is accurately reflected in procedural documents.
· Vendor & Project Integration: Contribute to vendor selection and qualification, providing pro-active quality oversight for GxP critical systems and processes.
· Execution & Validation: Direct the CSV approach for project teams, supervising the creation and approval of deliverables, test defects, and risk mitigation activities.
· Lifecycle Management: Oversee the computerized system portfolio, managing change controls, periodic reviews, and maintenance activities after "Business Go-live".
· Internal Advisory: Act as an expert advisor on CSV regulations, supporting AI projects from a regulatory/validation standpoint and mentoring staff on CSLC activities.
· Leadership & Quality: Manage and develop the CSV team, identify areas for process improvement, and assist with CAPA formulation and audit planning.
Requirements
· Education: Minimum of a Master’s degree in Science, Engineering, or a Clinical discipline.
· Experience: Over 15 years in Quality Management within the pharmaceutical industry, with at least 5 years specifically dedicated to CSV and qualification.
· Technical Expertise: Strong working knowledge of GxP, 21 CFR Part 11, EU Annex 11, GAMP 5, and ICH GCP E6.
· Auditing: Proven experience in managing and conducting audits.
· Leadership Style: A strategic thinker who applies a risk-based approach and can balance high-level oversight with daily operational efficiency.
· Soft Skills: Deliverables-driven, pragmatic, and able to thrive in a dynamic, fast-paced environment.
· Languages: Fluent in English; fluency in French an asset.
Benefits
What we Offer:
· Being part of a company where innovation, collaboration, and impact aren’t just values — they’re how we work every day
· Partner with teams across disciplines, at the forefront of oncology and anti-infective development
· An inclusive and respectful workplace — proud to be Equal-Pay certified
· Grow in a culture that values people, purpose, and performance
· A chance to grow, share, and shape the future of healthcare
What to Expect in the Recruitment Process:
If your application is selected, you’ll be invited to interviews with Talent Acquisition and the Hiring Manager via Teams, followed by a panel interview and reference checks. Communication is handled via Workable—check your spam folder for emails from *@outbound.workable.com
Please contact our HR Department prior to submitting any profiles. We cannot accept unsolicited applications from agencies or recruiters.
Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe.
Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections.
Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®
If your university or biotech start-up has interesting molecules in early-stage research and you’re seeking a competent and committed partner to develop them further, please contact us!
